Cite
HARVARD Citation
Blauvelt, A. et al. (2018). Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches. British journal of dermatology. pp. 623-631. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Blauvelt, A. et al. (2018). Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches. British journal of dermatology. pp. 623-631. [Online].